We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Direct-to-Stomach Drug Release Could Reduce TB Burden

News   Mar 19, 2019 | Original story by Anne Trafton, MIT

 
Device Would Allow TB Dosing to Switch From Daily to Monthly

A representative prototype of a gastric resident device researchers have created to slowly release antibiotics in a patient's stomach over time. Image credit: Malvika Verma, Karan Vishwanath, MIT

 
 
 

RELATED ARTICLES

RNA Folding Insights Lead to New Therapeutics and Synthetic Biology Technologies

News

A research team has uncovered a new understanding of how RNA molecules act as cellular "biosensors" to monitor and respond to changes in the environment by controlling gene expression.

READ MORE

New CRISPR Editing System a "Genetic Word Processor"

News

A team from the Broad Institute of MIT and Harvard has developed a new CRISPR genome-editing approach by combining two of the most important proteins in molecular biology -- CRISPR-Cas9 and a reverse transcriptase -- into a single machine.

READ MORE

Medieval Super-yeasts Make a Belgian Beer!

News

Scientists have found that some of the most renowned classic Belgian beers, including Gueuze and Trappist ales, are fermented with a rare and unusual form of hybrid yeasts.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE